ScoreWhy is Suven Life Sciences Ltd ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -23.11% and Operating profit at -186.11% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -149.78
2
The company has declared Negative results for the last 5 consecutive quarters
- PAT(Q) At Rs -77.31 cr has Fallen at -67.9% (vs previous 4Q average)
- OPERATING CF(Y) Lowest at Rs -47.39 Cr
- CASH AND CASH EQUIVALENTS(HY) Lowest at Rs 10.79 cr
3
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 26.97%, its profits have fallen by -45.2%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Healthcare Services)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Suven Life Scie. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Suven Life Scie.
14.05%
0.48
55.77%
Sensex
8.49%
0.44
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-19.24%
EBIT Growth (5y)
-204.12%
EBIT to Interest (avg)
-165.17
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.92
Sales to Capital Employed (avg)
0.16
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
4.46%
ROCE (avg)
-240.93%
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
32
Price to Book Value
12.29
EV to EBIT
-11.30
EV to EBITDA
-11.52
EV to Capital Employed
134.51
EV to Sales
452.42
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-921.36%
ROE (Latest)
-75.33%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend0What is working for the Company
NO KEY POSITIVE TRIGGERS
-14What is not working for the Company
PBDIT(Q)
Lowest at Rs -103.35 cr.
PBT LESS OI(Q)
Lowest at Rs -104.69 cr.
PAT(Q)
Lowest at Rs -101.92 cr.
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 10.79 cr
EPS(Q)
Lowest at Rs -4.48
Loading Valuation Snapshot...
Here's what is not working for Suven Life Scie.
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs -104.69 cr has Fallen at -91.1% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs -54.78 CrMOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs -101.92 cr has Fallen at -92.4% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs -52.97 CrMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Lowest at Rs -103.35 cr. and Fallen
each quarter in the last five quartersMOJO Watch
Near term Operating Profit trend is quite negative
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs -104.69 cr. and Fallen
each quarter in the last five quartersMOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Lowest at Rs -101.92 cr. and Fallen
each quarter in the last five quartersMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Lowest at Rs -4.48
in the last five quartersMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (Rs)
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 10.79 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
